{"slideshow_credits": null, "snippet": "The activist investor Carl C. Icahn is a major beneficiary of the $25 billion deal by Actavis to buy Forest Laboratories, but the path to victory was an uncertain one.", "abstract": "The activist investor Carl C. Icahn is a major beneficiary of the $25 billion deal by Actavis to buy Forest Laboratories, but the path to victory was an uncertain one.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "William", "role": "reported", "lastname": "ALDEN", "rank": 1, "organization": ""}], "original": "By WILLIAM ALDEN"}, "web_url": "http://dealbook.nytimes.com/2014/02/18/for-icahn-drug-maker-deal-came-after-a-long-fight/", "lead_paragraph": null, "headline": {"main": "For Icahn, Drug Maker Deal Came After a Long Fight", "kicker": "DealBook"}, "_id": "5303898b38f0d821d3f24b1b", "word_count": "665", "multimedia": [{"height": 126, "url": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 788, "url": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-articleLarge.jpg", "legacy": {"xlarge": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "788"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/02/18/business/dealbook/dbpix-icahn/dbpix-icahn-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-02-18T11:24:33Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Icahn, Carl C", "rank": "1"}, {"name": "persons", "value": "Saunders, Brent", "rank": "2"}, {"name": "organizations", "value": "Forest Laboratories Inc", "rank": "2"}, {"name": "organizations", "value": "Actavis Group", "rank": "1"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Boards of Directors", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}